Wealthcare Advisory Partners LLC Increases Stake in Oracle Co. (NYSE:ORCL)

Wealthcare Advisory Partners LLC boosted its holdings in Oracle Co. (NYSE:ORCL - Free Report) by 9.3% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 38,341 shares of the enterprise software provider's stock after acquiring an additional 3,269 shares during the period. Wealthcare Advisory Partners LLC's holdings in Oracle were worth $5,360,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. McClarren Financial Advisors Inc. boosted its position in shares of Oracle by 201.7% during the fourth quarter. McClarren Financial Advisors Inc. now owns 1,599 shares of the enterprise software provider's stock worth $266,000 after buying an additional 1,069 shares during the period. Cornerstone Advisory LLC boosted its holdings in Oracle by 34.1% during the 4th quarter. Cornerstone Advisory LLC now owns 12,968 shares of the enterprise software provider's stock valued at $2,258,000 after acquiring an additional 3,299 shares during the period. Peak Retirement Planning Inc. purchased a new stake in Oracle during the fourth quarter worth about $211,000. AFT Forsyth & Company Inc. lifted its position in shares of Oracle by 32.7% during the fourth quarter. AFT Forsyth & Company Inc. now owns 6,739 shares of the enterprise software provider's stock worth $1,123,000 after purchasing an additional 1,659 shares in the last quarter. Finally, Certuity LLC boosted its stake in shares of Oracle by 28.9% in the fourth quarter. Certuity LLC now owns 7,811 shares of the enterprise software provider's stock valued at $1,302,000 after purchasing an additional 1,753 shares during the period. Institutional investors and hedge funds own 42.44% of the company's stock.

Insider Activity

In other Oracle news, Director Naomi O. Seligman sold 2,000 shares of the stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $145.81, for a total transaction of $291,620.00. Following the sale, the director now owns 34,630 shares in the company, valued at approximately $5,049,400.30. This represents a 5.46% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Vice Chairman Jeffrey Henley sold 400,000 shares of the company's stock in a transaction on Thursday, June 12th. The shares were sold at an average price of $190.42, for a total value of $76,168,000.00. Following the completion of the sale, the insider now owns 1,097,576 shares in the company, valued at $209,000,421.92. This represents a 26.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 427,366 shares of company stock worth $80,183,723 over the last 90 days. 42.20% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on ORCL. Evercore ISI increased their target price on shares of Oracle from $180.00 to $215.00 and gave the stock an "outperform" rating in a report on Thursday. Westpark Capital boosted their target price on Oracle from $195.00 to $246.00 and gave the stock a "buy" rating in a research note on Thursday. Barclays increased their price target on Oracle from $202.00 to $221.00 and gave the company an "overweight" rating in a research report on Friday. CIBC reiterated a "buy" rating on shares of Oracle in a research note on Monday. Finally, Royal Bank of Canada upped their target price on shares of Oracle from $145.00 to $195.00 and gave the stock a "sector perform" rating in a research note on Thursday. Twelve research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $194.32.

Oracle Stock Performance

Oracle stock traded up $15.68 during trading hours on Friday, reaching $215.54. 53,639,099 shares of the stock were exchanged, compared to its average volume of 9,727,788. Oracle Co. has a 52-week low of $118.86 and a 52-week high of $216.60. The stock has a market cap of $602.86 billion, a P/E ratio of 52.70, a P/E/G ratio of 3.46 and a beta of 1.32. The company has a debt-to-equity ratio of 5.65, a quick ratio of 0.81 and a current ratio of 0.81. The firm's 50 day moving average is $152.88 and its 200 day moving average is $160.62.

Oracle (NYSE:ORCL - Get Free Report) last issued its earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.64 by $0.06. Oracle had a return on equity of 133.25% and a net margin of 21.16%. The business had revenue of $15.90 billion during the quarter, compared to the consensus estimate of $15.58 billion. During the same period in the prior year, the business posted $1.63 EPS. The company's revenue for the quarter was up 11.3% on a year-over-year basis. Analysts predict that Oracle Co. will post 5 EPS for the current fiscal year.

Oracle Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, July 24th. Shareholders of record on Thursday, July 10th will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.93%. The ex-dividend date is Thursday, July 10th. Oracle's dividend payout ratio (DPR) is 46.08%.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.